US Executive Compensation Proxy SEC Filings — July 29, 2026

Executive Compensation Insights

By Gunpowder Editorial ·

8 high priority 8 total filings analysed

Executive Summary

The eight DEF 14A filings for the 2026 proxy season reveal a governance landscape dominated by capital structure maneuvers and insider control dynamics, rather than broad-based executive compensation trends.

The most critical development is at Earth Science Tech, where a CEO with 43% common stock ownership and all super-voting Series B Preferred shares seeks shareholder authorization to negotiate his own buyout, creating a profound conflict of interest. Quantum Corporation stands out with a positive narrative of debt elimination and revenue improvement, contrasting with the cash-centric, dilutive concerns at Earth Science Tech. A significant trend is the prevalence of share increase and incentive plan amendments, with Replimune seeking to double its authorized shares and Powerfleet adding 8.4 million shares to its incentive plan, suggesting a broad need for equity currency. The SPAC Alchemy Investments is racing against a September 2026 deadline to close its business combination with Cartiga, LLC, introducing a binary catalyst. Overall, the filings indicate a market where management is seeking more equity flexibility, while investors must scrutinize governance proposals that could significantly dilute or entrench existing control.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: DEF 14A

Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from July 27, 2026.

Investment Signals (8)

  • Quantum Corporation (BULLISH)

    Achieved debt elimination and consistent revenue improvement, signaling a successful turnaround. The positive sentiment in the filing and the proposed amendment to the 2023 Long-Term Incentive Plan suggest management is confident in future growth and wants to retain key talent

  • CEO Giorgio R. Saumat holds 43% of common stock and all Series B Preferred shares, giving him effective control. The non-binding proposal to authorize negotiations for his own buyout introduces severe governance risk and potential for value extraction from minority shareholders

  • Has a signed business combination agreement with Cartiga, LLC, creating a clear catalyst. The sponsor's commitment to fund monthly extensions (lesser of $30k or $0.03/share) until September 2027 provides a backstop, but the tight timeline to the September 1, 2026 meeting creates a binary event [BULLISH/BEARISH]

  • Proposal to double authorized shares from 150M to 300M (100% increase) signals potential for significant future dilution or a major acquisition. This is a high-magnitude capital structure change that warrants close monitoring [NEUTRAL/BEARISH]

  • Amending the 2018 Incentive Plan to add 8.4 million shares (6.3% of outstanding shares) and extend the term to 2036 suggests a need to refresh equity compensation for a larger workforce post-merger or to retain key executives

  • Audit committee met 16 times during fiscal 2026, which is exceptionally high and suggests either intensive oversight of complex financials or potential control issues. This frequency is a red flag for governance scrutiny

  • Proposing a Second Amendment to the 2022 Incentive Award Plan, indicating a need to adjust compensation strategy. The majority voting standard for directors in uncontested elections is a shareholder-friendly governance feature

  • Standard governance proposals with no contentious items. The staggered board structure (three classes, three-year terms) is a traditional anti-takeover defense that may be viewed negatively by activist investors [NEUTRAL/BEARISH]

Risk Flags (8)

  • CEO holds super-voting Series B Preferred stock and is seeking shareholder authorization to negotiate his own buyout. This is a textbook conflict of interest with high risk of minority shareholder value destruction

  • CEO base salary of $1,758,000 vs CFO base salary of $160,000 (11:1 ratio) with no equity compensation. This extreme disparity and cash-centric model may misalign incentives and signal poor governance

  • Advisory vote on a reverse stock split (1-for-2 to 1-for-30) to facilitate an uplisting. A 1-for-30 split would be highly dilutive to share count and often signals financial distress

  • Business combination must close by September 9, 2026, with the annual meeting on September 1, 2026. Any delay or failure to secure shareholder approval could lead to liquidation, making this a high-risk binary event

  • Authorized share increase from 150M to 300M (100% increase) without a specific stated use (e.g., acquisition). This creates overhang and potential for massive dilution

  • 16 audit committee meetings in a single fiscal year is an outlier. This could indicate complex accounting issues, internal control weaknesses, or heightened regulatory scrutiny

  • Quantum Corporation/Supply Chain Challenges [MEDIUM RISK]

    The filing explicitly acknowledges ongoing supply chain challenges despite positive revenue trends. This could cap margin expansion and growth in coming quarters

  • The Second Amendment to the 2022 Incentive Award Plan could increase the pool of shares available for issuance, potentially diluting existing shareholders if not properly capped

Opportunities (8)

  • Quantum Corporation/Turnaround Play (OPPORTUNITY)

    Debt elimination and consistent revenue improvement provide a strong foundation. The positive sentiment and proposed LTIP amendment suggest management is confident. If supply chain issues resolve, the stock could re-rate significantly

  • The business combination with Cartiga, LLC creates a potential arbitrage opportunity. Investors can assess the deal valuation and decide whether to redeem shares or hold through the merger, with the sponsor's extension commitment reducing liquidation risk

  • The increase in authorized shares for the incentive plan (8.4M shares) suggests the company is positioning to retain talent after a potential merger or growth phase. If execution is strong, this could be a catalyst for outperformance

  • The authorized share increase could be a precursor to a strategic acquisition or partnership. If the company has a promising pipeline candidate, the dilution could be justified by future value creation

  • Majority voting standard for directors and a clear proxy timeline suggest a shareholder-friendly approach. If the company executes on its operational strategy, the stock could benefit from improved governance perception

  • As a biotech with a clean proxy and no contentious items, Roivant offers a lower-risk governance profile. The London AGM location and staggered board may appeal to long-term, non-activist investors

  • While 16 audit committee meetings is a risk, it could also signal that management is proactively addressing issues. If the company resolves any underlying concerns, the stock could see a governance premium

  • The extreme governance issues (CEO buyout, super-voting shares, reverse split) could attract activist investors or short sellers. A proxy fight or regulatory intervention could unlock value for minority shareholders

Sector Themes (5)

  • Equity Dilution as a Tool

    3 of 8 companies (Replimune, Powerfleet, Motorcar Parts) are seeking to increase authorized shares or amend incentive plans. This suggests a broad trend of companies using equity as currency for compensation, M&A, or balance sheet flexibility, which investors should monitor for dilution risk.

  • Governance Conflict in Micro-Caps

    Earth Science Tech exemplifies the extreme governance risks present in smaller, controlled companies. The CEO's super-voting shares and proposed self-buyout highlight the need for investors to scrutinize control structures and related-party transactions.

  • SPAC Deadline Pressure

    Alchemy Investments' filing underscores the ongoing pressure on SPACs to complete de-SPAC transactions before their deadlines. With the September 2026 deadline looming, investors should watch for similar filings from other SPACs as a source of binary risk/reward.

  • Audit Committee Intensity as a Signal

    Freedom Holding Corp.'s 16 audit committee meetings is an outlier. This pattern, if observed across other filings, could indicate a broader trend of increased audit scrutiny post-SOX or specific company-level issues requiring attention.

  • Cash vs. Equity Compensation

    Earth Science Tech's cash-centric compensation (no equity) contrasts with the incentive plan amendments at Quantum, Powerfleet, and Motorcar Parts. This divergence highlights different strategies for aligning management with shareholders, with equity-based plans generally preferred for long-term alignment.

Watch List (8)

  • September 1, 2026 meeting to vote on extension and business combination. Watch for shareholder redemption levels and any last-minute deal renegotiations.

  • The non-binding vote on authorizing negotiations to purchase Series B Preferred stock. Any news of actual negotiations or CEO response will be critical.

  • Quantum Corporation/Supply Chain Update
    👁

    Watch for Q3/Q4 earnings calls for updates on supply chain challenges and whether revenue improvement can be sustained.

  • The outcome of the authorized share increase proposal. If passed, watch for subsequent announcements of acquisitions or capital raises.

  • The amendment to the 2018 Incentive Plan. Passage could signal upcoming equity grants to new hires or executives, indicating growth plans.

  • Watch for any 8-K filings or earnings releases that reference the work of the audit committee, which met 16 times in FY2026.

  • The Second Amendment to the 2022 Plan. Watch for the specific number of shares added and any changes to award types.

  • September 16, 2026 AGM. While standard, any significant vote against director elections or say-on-pay could signal shareholder discontent.

Filing Analyses (8)
Replimune Group, Inc. DEF 14A neutral materiality 3/10

29-07-2026

Replimune Group, Inc. filed a DEF 14A proxy statement for its upcoming virtual Annual Meeting, seeking stockholder approval on three proposals: ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and an amendment to increase authorized common shares from 150,000,000 to 300,000,000. The filing provides detailed voting instructions and notes that the record date had 84,026,071 shares outstanding. No financial results or performance metrics are disclosed in this filing.

  • · The annual meeting will be held virtually at www.meetnow.global/MP4F5JS on a date to be determined.
  • · Stockholders must have a 15-digit control number to vote or ask questions; guests cannot vote or ask questions.
  • · Proposal 1 (auditor ratification) and Proposal 3 (share increase) are considered 'routine' matters; Proposal 2 (say-on-pay) is 'non-routine'.
  • · Abstentions on Proposal 1 count as votes against ratification.
  • · The company will bear all proxy solicitation costs.
Roivant Sciences Ltd. DEF 14A neutral materiality 2/10

29-07-2026

Roivant Sciences Ltd. filed a definitive proxy statement (DEF 14A) for its 2026 Annual General Meeting to be held on September 16, 2026, in London. The meeting will include the election of two Class II directors (Daniel Gold and Meghan FitzGerald), ratification of Ernst & Young LLP as auditor for fiscal 2027, and a non-binding advisory vote on executive compensation. The filing provides standard governance proposals with no contentious items or material financial disclosures.

  • · Annual Meeting will be held at Royal Lancaster London Hotel, London, UK on September 16, 2026 at 10:30 a.m. local time.
  • · Record date for voting is July 23, 2026.
  • · Board currently has 8 members divided into three classes with staggered three-year terms.
  • · Proposals include: (1) election of two Class II directors, (2) ratification of EY as auditor, (3) non-binding advisory vote on executive compensation.
  • · Board recommends a vote FOR ALL nominees and FOR all proposals.
Earth Science Tech, Inc. DEF 14A mixed materiality 8/10

29-07-2026

Earth Science Tech, Inc. (ETST) filed a DEF 14A proxy statement for its 2026 Annual Meeting, seeking stockholder votes on five proposals including ratification of auditor Semple, Marchal & Cooper, LLP, an advisory vote to authorize negotiations to purchase and retire Series B Preferred Stock (which carries super-voting powers held by CEO Giorgio R. Saumat), a non-binding advisory vote to pursue a reverse stock split (1-for-2 to 1-for-30) to facilitate an uplisting, and an advisory say-on-pay vote on executive compensation. The filing highlights a governance conflict of interest with the CEO, who holds 43% of outstanding common stock and all Series B Preferred Stock, and notes that the Series B buyout is non-binding and the CEO is under no obligation to accept any offer. The company's current compensation packages include CEO base salary of $1,758,000 per annum and a performance bonus of $1,447,735, while the CFO's base salary is only $160,000 per annum, indicating a significant disparity.

  • · The Series B Preferred Stock buyout is non-binding and the CEO is under no legal obligation to accept any offer.
  • · The reverse stock split ratio range is 1-for-2 to 1-for-30, and the advisory recommendation expires after 12 months.
  • · The company's compensation philosophy is strictly cash-centric, with no stock bonuses or equity-based compensation to avoid dilution.
  • · The CFO's base salary ($160,000) is significantly lower than the CEO's ($1,758,000) and COO's ($1,324,000).
  • · The Board has formed an independent Special Committee to negotiate the Series B buyout due to the conflict of interest with the CEO.
QUANTUM CORP /DE/ DEF 14A positive materiality 6/10

29-07-2026

Quantum Corporation filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders to be held on September 15, 2026. The company highlights significant achievements over the past year including debt elimination, balance sheet strengthening, increased enterprise value, and consistent revenue improvement, while also acknowledging ongoing supply chain challenges. The Board recommends voting FOR all four proposals: election of directors, amendment and restatement of the 2023 Long-Term Incentive Plan, non-binding advisory vote on executive compensation, and ratification of the independent auditor.

  • · Annual Meeting to be held virtually on September 15, 2026 at 8:30 a.m. Pacific Time.
  • · Record date for voting is July 20, 2026.
  • · Proxy materials first sent on or about July 29, 2026.
  • · Proposals include: election of directors, amendment and restatement of the 2023 Long-Term Incentive Plan, non-binding advisory vote on executive compensation, and ratification of the independent auditor.
  • · Board recommends FOR all proposals.
  • · Company eliminated its debt, strengthened balance sheet, increased enterprise value, and demonstrated consistent revenue improvement over the past year.
  • · Company faces new supply chain challenges.
  • · Hugues Meyrath became President and CEO on June 2, 2025.
  • · Donald J. Jaworski was named Chairman on June 2, 2025.
  • · Todd W. Arden served on the Board for the April 1-2, 2025 portion of Fiscal 2026 and had no disagreements with the Board or management.
  • · No familial relationships exist between any directors or executive officers.
Alchemy Investments Acquisition Corp 1 DEF 14A neutral materiality 7/10

29-07-2026

Alchemy Investments Acquisition Corp 1 (ALCYU) filed a definitive proxy statement (DEF 14A) for its annual general meeting scheduled for September 1, 2026. The meeting will consider three proposals: an extension of the deadline to complete a business combination from September 9, 2026 to September 9, 2027 (Extension Proposal), ratification of CBIZ CPAs P.C. as auditor for fiscal year 2026, and an adjournment proposal if needed. The company has already entered into a business combination agreement with Cartiga, LLC on August 22, 2025, which will result in a domestication to Delaware and an 'Up-C' structure with the combined entity renamed Cartiga Holdings, Inc. The sponsor, Alchemy DeepTech Capital LLC, has agreed to fund monthly contributions of the lesser of $30,000 or $0.03 per non-redeemed public share to extend the deadline, with such loans repayable only upon consummation of the business combination.

  • · The business combination agreement was unanimously approved by ALCY's directors on August 19, 2025.
  • · The extension period can run month-to-month until September 9, 2027, with each monthly extension requiring a sponsor contribution.
  • · Shareholders have redemption rights and must tender shares by August 28, 2026 (two business days prior to the meeting).
  • · Founder shareholders (3,413,000 shares) have waived their rights to liquidating distributions from the trust account if no business combination is completed.
  • · Sponsor loans for extension contributions are non-interest bearing and will be forgiven if the business combination is not consummated, except for funds held outside the trust account.
  • · The board recommends voting FOR all three proposals.
Freedom Holding Corp. DEF 14A neutral materiality 5/10

29-07-2026

Freedom Holding Corp. filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting of stockholders, to be held virtually on September 16, 2026. The meeting will include the election of two Class I directors, a non-binding advisory vote on named executive officer compensation, and ratification of Deloitte LLP as independent auditor for fiscal 2027. The audit committee met 16 times during fiscal 2026, reflecting intensive oversight, and the company reported no changes to audit committee composition.

  • · Record date for the 2026 Annual Meeting is July 20, 2026.
  • · Proxy materials will be mailed to stockholders beginning on or about August 4, 2026.
  • · The audit committee is composed of Amber Williams (Chair), Boris Cherdabayev, and Andrew Gamble, all independent under Nasdaq Rule 5605.
  • · Amber Williams qualifies as an audit committee financial expert under SEC rules.
  • · No changes were made to the audit committee composition during fiscal 2026.
MOTORCAR PARTS OF AMERICA INC DEF 14A neutral materiality 5/10

29-07-2026

Motorcar Parts of America Inc. filed its definitive proxy statement (DEF 14A) on July 29, 2026, for the 2026 Annual Meeting of Shareholders to be held on September 10, 2026. The meeting will include the election of eight director nominees, ratification of Ernst & Young LLP as independent auditor, an advisory vote on executive compensation, and approval of the Second Amendment to the 2022 Incentive Award Plan. The record date is July 15, 2026, with 18,933,207 shares of common stock outstanding.

  • · The meeting will be held at 10:00 a.m. PT on September 10, 2026, at 2929 California Street, Torrance, California 90503.
  • · Proxy materials are available at https://materials.proxyvote.com/620071 and were first made available on July 29, 2026.
  • · The voting standard for director election in an uncontested election is a majority of votes cast; abstentions and broker non-votes have no effect.
  • · Douglas Trussler is not independent due to the Company's ongoing obligations related to the Convertible Note Transaction that closed on March 31, 2023.
  • · The Board recommends a vote FOR all four proposals.
Powerfleet, Inc. DEF 14A neutral materiality 5/10

29-07-2026

Powerfleet, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on September 16, 2026. The meeting will cover the election of four directors, ratification of Deloitte & Touche as auditor for FY2027, an advisory vote on executive compensation, and an amendment to the 2018 Incentive Plan to increase authorized shares by 8.4 million and extend the plan term to 2036. As of the July 24, 2026 record date, the company had 134,225,918 shares of common stock outstanding.

  • · The annual meeting will be held virtually only at www.meetnow.global/MNDCGHN.
  • · The record date for voting is July 24, 2026.
  • · The proxy materials are available at https://ir.powerfleet.com/proxy-materials.
  • · The 2018 Plan amendment also proposes to extend the plan term from 2028 to 2036 and amend minimum vesting provisions.
  • · Ratification of Deloitte & Touche is considered a routine matter; all other proposals are non-routine.
  • · A plurality vote is required for director election; a majority of votes cast is required for the other proposals.

Get daily alerts with 8 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 8 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Executive Compensation Proxy SEC Filings

🇺🇸 More from United States

View all →